Background Late cardiac toxicities caused by (particularly left-sided) breast radiotherapy
(RT) are now recognized as rare but relevant sequelae, which has prompted research on …

The use of charged particle therapy to control tumours non-invasively offers advantages
over conventional radiotherapy. Protons and heavy ions deposit energy far more selectively …

Background 5-year results of the UK Standardisation of Breast Radiotherapy (START) trials
suggested that lower total doses of radiotherapy delivered in fewer, larger doses (fractions) …

Moderate hyperthermia at temperatures between 40 and 44° C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Importance To promptly recognize and manage cardiovascular (CV) risk factors before,
during, and after cancer treatment, decreasing the risk of cancer therapy–related cardiac …

Chest radiotherapy is routinely used to treat malignancies such as Hodgkin disease and
breast cancer but is commonly associated with a variety of cardiovascular complications …

Simple Summary Given that the majority of breast cancer patients receive adjuvant radiation
therapy and/or systemic treatments that can enhance cardiovascular risk, it is imperative to …

Long-term cardiac effects are an important component of survivorship after breast
radiotherapy. The pathophysiology of cardiotoxicity, history of breast radiotherapy, current …

Radiation therapy has a prime importance for breast cancer management. However, first-
generation techniques delivered significant radiation dose to the heart, which substantially …

Cardiotoxicity of various anticancer therapies, including radiotherapy (RT), can lead to
cardiovascular (CV) complications, and their severity depends on many factors, including …